Sign in
Explore the registryTrack Anitocabtagene autoleucel's trials

iMMagine-3

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

Anitocabtagene AutoleucelOngoingActive not recruitingPhase 3Open NCT06413498 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…